SINOPHARM CAPITAL
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and is based in Shanghai, China.
SINOPHARM CAPITAL
Industry:
Angel Investment Finance Financial Services Health Care Venture Capital
Founded:
2012-06-01
Status:
Active
Contact:
86 21 6333 7900
Technology used in webpage:
GlobalSign Alibaba Tengine HiChina
Similar Organizations
Color Capital
Color Capital invests in things people buy, and how they buy them.
Oceanpine Capital
Oceanpine Capital is a professional investment management firm dedicated to long-term investment with a focus on value creation.
Current Advisors List
Board_member
Current Employees Featured
Xiaoming Yang Managing Director @ Sinopharm Capital
Managing Director
Aimin Wu President @ Sinopharm Capital
President
Yunlei Gong Vice-President @ Sinopharm Capital
Vice-President
2012-03-01
Fei Jiang Executive Vice-President @ Sinopharm Capital
Executive Vice-President
2019-01-01
Yong Kuang Managing Director @ Sinopharm Capital
Managing Director
Shengtao Zhu Managing Director @ Sinopharm Capital
Managing Director
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-08-23 | MXB Biotechnologies | MXB Biotechnologies acquired by Sinopharm Capital | 2.63 B CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-31 | Metanovas | Sinopharm Capital investment in Seed Round - Metanovas | 10 M USD |
| 2022-03-31 | Artivila Therapeutics | Sinopharm Capital investment in Seed Round - Artivila Therapeutics | 100 M CNY |
| 2021-12-13 | Xishan | Sinopharm Capital investment in Series D - Xishan | 100 M CNY |
| 2021-12-07 | Sumgen Biotech | Sinopharm Capital investment in Venture Round - Sumgen Biotech | N/A |
| 2021-11-26 | Longhui Medical | Sinopharm Capital investment in Series B - Longhui Medical | 100 M CNY |
| 2021-11-15 | Sepax Technologies | Sinopharm Capital investment in Series D - Sepax Technologies | 500 M CNY |
| 2021-11-02 | Shanghai Ouyi Biomedical Technology | Sinopharm Capital investment in Series A - Shanghai Ouyi Biomedical Technology | 100 M CNY |
| 2021-10-01 | Brise Pharma | Sinopharm Capital investment in Angel Round - Brise Pharma | 150 M CNY |
| 2021-09-28 | Geneus | Sinopharm Capital investment in Series B - Geneus | N/A |
| 2021-05-06 | Yikon Genomics | Sinopharm Capital investment in Series D - Yikon Genomics | 250 M CNY |
More informations about "Sinopharm Capital"
Sinopharm Capital investment portfolio - PitchBook
Sinopharm Capital General Information Company Description. Sinopharm Capital is a venture capital arm of Sinopharm Group focusing on medical and health fields. The firm is primarily based in Shanghai, China and prefers to invest in …See details»
Sinopharm Capital
Sinopharm Capital is the private equity and venture capital arm of China National Pharmaceutical Group Corporation, primarily focused on investments in the medical and healthcare sectors, …See details»
Sinopharm Capital - Investments, Portfolio & Company Exits
Sinopharm Capital 's most notable exits include Abbisko Therapeutics, Semma Therapeutics, and InventisBio. Which industries has this organization had the most exits in? Show . Abbisko …See details»
Sinopharm Capital Portfolio Companies - Crunchbase
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation. This list of organizations invested in by Sinopharm Capital provides data on their funding …See details»
Sinopharm Capital | Institution Profile - Private Equity International
Sinopharm Capital contact information Offices 16th Floor, No.266, Hankou Road, Huangpu District,, Shanghai, 200001, China Showing 1 of 1 Sinopharm Capital officesSee details»
Sinopharm CICC investment portfolio - PitchBook
Sinopharm CICC General Information Company Description. Founded in 2016, Sinopharm CICC is a private equity investment fund management company based in Shanghai, China. The company was jointly initiated and established …See details»
Sinopharm Capital - CB Insights
Jun 21, 2019 About Sinopharm Capital. Sinopharm Capital, under Sinopharm Group, is a professional PE company specialized in medical and healthcare industry. The funds are …See details»
Sinopharm capital officially changed its name to "Jianyi capital" …
Jan 19, 2022 On the 19th, yiouda health learned that the former Sinopharm capital held the "Jianyi capital 2021 fund Partner Conference and new brand press conference" in Shanghai, …See details»
Sinopharm (company) - Wikipedia
China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise.The corporation was the indirect major …See details»
Sinopharm Capital - Golden
Sinopharm Capital. A private equity firm in China that focuses on medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and …See details»
Sinopharm Capital Management Co Ltd - Company Profile and News
Company profile page for Sinopharm Capital Management Co Ltd including stock price, company news, executives, board members, and contact informationSee details»
Sinopharm Capital - Funding, Financials, Valuation & Investors
Jun 21, 2019 Sinopharm Capital . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 1. Funding. …See details»
China's Sinopharm to extend its reach into Southeast Asia
Jun 12, 2019 SINGAPORE -- Sinopharm Capital will launch a $150 million investment fund to tap into the growing Southeast Asian healthcare market. The private equity arm of state …See details»
Sinopharm Company Profile, Stock Price, News, Rankings - Fortune
Sinopharm in Fortune Rankings. 112 Fortune Global 500. Company Information Key Financials (last Fiscal Year) Profit Ratios. Company Information. Company Information;See details»
SinoPharm Capital - VC Firm Profile - Gaebler.com Venture Capital …
SinoPharm Capital is a VC firm that specializes in funding high-potential tech companies. Venture Investor Overview. Venture Investor. SinoPharm Capital. Status. InActive. Investor Type. …See details»
Sinopharm Group: The Focus Is On Working Capital And Profitability
Nov 21, 2024 Sinopharm Group's days sales outstanding increased from 116 days in Q4 2023 to 132 days in Q1 2024, before rising further to 150 days for both Q2 2024 and Q3 2024 as per …See details»
Sinopharm-CICC - Crunchbase Investor Profile & Investments
Also Known As Yaojin Capital, Yaojin (Shanghai) Private Equity, Sinopharm Zhongjin, 国药中金, 曜金（上海）私募基金管理有限公司, 中金私募; Legal Name Yaojin (Shanghai) Private …See details»
Trump Organization sues Capital One for closing its bank accounts …
Mar 7, 2025 President Donald Trump’s business trust sued Capital One for closing its bank accounts in 2021, claiming the North Carolina lender “debanked” them over their political …See details»
China's Sinopharm to extend its reach into Southeast Asia
Jun 21, 2019 SINGAPORE -- Sinopharm Capital will launch a $150 million investment fund to tap into the growing Southeast Asian healthcare market. The private equity arm of state …See details»
Trump Organization Sues Capital One for Closing Its Accounts
Mar 7, 2025 President Trump’s family business sued Capital One on Friday for “unjustifiably terminating” more than 300 of its bank accounts after the Jan. 6, 2021, attack on the Capitol, …See details»